Literature DB >> 17537136

Ultrasound as an outcome measure to assess disease activity in disorders of skin thickening: an example of the use of radiologic techniques to assess skin disease.

Sandra E Bendeck1, Heidi T Jacobe.   

Abstract

Good outcome measures are required to determine whether a therapy is effective, both in routine clinical practice and in experimental clinical trials. In disorders of skin thickening such as morphea and scleroderma, more commonly used outcome measures that use a subjective score based on palpated skin thickening are fraught with error. By contrast, measurements made by ultrasound have great promise as outcome measures that are quantitative, valid, reproducible, and responsive. Further studies should establish its role in the field. In this paper, the present authors used ultrasound to illustrate the criteria that are required to establish a technology-based outcome measure.

Entities:  

Mesh:

Year:  2007        PMID: 17537136     DOI: 10.1111/j.1529-8019.2007.00116.x

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN: 1396-0296            Impact factor:   2.851


  12 in total

1.  Technical feasibility of real-time elastography to assess the peri-oral region in patients affected by systemic sclerosis.

Authors:  Paola Maria Cannaò; Valeriano Vinci; Fabio Caviggioli; Marco Klinger; Davide Orlandi; Francesco Sardanelli; Giovanni Serafini; Luca Maria Sconfienza
Journal:  J Ultrasound       Date:  2014-07-29

Review 2.  The use of Doppler ultrasound to evaluate lesions of localized scleroderma.

Authors:  Suzanne C Li; Melissa S Liebling
Journal:  Curr Rheumatol Rep       Date:  2009-07       Impact factor: 4.592

3.  The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.

Authors:  Ki Won Moon; Ran Song; Jin Hyun Kim; Eun Young Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Rheumatol Int       Date:  2011-07-19       Impact factor: 2.631

Review 4.  Recent developments in diagnosis and assessment of morphea.

Authors:  Sarah Nouri; Heidi Jacobe
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

Review 5.  The role of ultrasound in rheumatic skin and nail lesions: a multi-specialist approach.

Authors:  Ximena Wortsman; Marwin Gutierrez; Tirza Saavedra; Juan Honeyman
Journal:  Clin Rheumatol       Date:  2010-11-26       Impact factor: 2.980

Review 6.  Why, how, and when to use color Doppler ultrasound for improving precision in the diagnosis, assessment of severity and activity in morphea.

Authors:  Ximena Wortsman
Journal:  J Scleroderma Relat Disord       Date:  2018-09-24

7.  Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Kathryn S Torok; Thomas A Medsger
Journal:  Rheumatology (Oxford)       Date:  2009-12-14       Impact factor: 7.580

Review 8.  [Systemic sclerosis. Objectives for the treatment].

Authors:  B Maurer; M Walder; R E Gay; S Gay; O Distler
Journal:  Z Rheumatol       Date:  2009-02       Impact factor: 1.372

Review 9.  [Morphea or localized scleroderma and extragenital lichen sclerosus].

Authors:  P Moinzadeh; A Kreuter; T Krieg; N Hunzelmann
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

10.  Correlates of self-reported quality of life in adults and children with morphea.

Authors:  Shinjita Das; Ira Bernstein; Heidi Jacobe
Journal:  J Am Acad Dermatol       Date:  2014-02-16       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.